Published in Int J Radiat Oncol Biol Phys on September 01, 2003
Modelling prognostic factors in advanced pancreatic cancer. Br J Cancer (2008) 1.53
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer (2005) 1.34
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer. BMC Cancer (2006) 1.31
Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Clin Cancer Res (2014) 1.00
Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials. Br J Cancer (2006) 0.96
Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma. Int J Clin Exp Pathol (2014) 0.90
Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. Br J Cancer (2010) 0.87
Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer. Med Oncol (2012) 0.84
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Oncol (2013) 0.83
Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation. Radiat Oncol (2012) 0.81
Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol (2012) 0.80
Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study. Int J Radiat Oncol Biol Phys (2012) 0.80
Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis. Radiat Oncol (2015) 0.79
53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. BMC Cancer (2013) 0.79
Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial. Oncotarget (2016) 0.78
Use of complementary and alternative medicine before and after organ removal due to urologic cancer. Patient Prefer Adherence (2015) 0.77
Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut (2005) 0.76
Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer. Radiat Oncol J (2014) 0.76
Metformin reduces serum CA199 levels in type 2 diabetes Chinese patients with time-effect and gender difference. Diabetes Technol Ther (2014) 0.75
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet (2003) 11.47
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol (2013) 2.97
Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest (2006) 2.25
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94
Mapping and identification of essential gene functions on the X chromosome of Drosophila. EMBO Rep (2001) 1.83
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2003) 1.70
"The artichoke heart": the inverse counterpart of left ventricular apical ballooning. Resuscitation (2006) 1.55
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol (2010) 1.46
Irradiation causes biphasic neutrophilic granulocyte phagocytic function. Strahlenther Onkol (2005) 1.40
The bronchiolar epithelium as a prominent source of pro-inflammatory cytokines after lung irradiation. Int J Radiat Oncol Biol Phys (2005) 1.24
[Radiotherapy in painful gonarthrosis. Results of a national patterns-of-care study]. Strahlenther Onkol (2009) 1.23
Perlecan participates in proliferation activation of quiescent Drosophila neuroblasts. Dev Dyn (2002) 1.22
Late effects of thoracic irradiation in children. Strahlenther Onkol (2008) 1.15
CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy. Anticancer Res (2003) 1.14
A Drosophila pasha mutant distinguishes the canonical microRNA and mirtron pathways. Mol Cell Biol (2008) 1.13
Mitochondrial and cytoplasmic thioredoxin reductase variants encoded by a single Drosophila gene are both essential for viability. J Biol Chem (2002) 1.12
Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung. Strahlenther Onkol (2004) 1.10
Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther Onkol (2009) 1.08
Apical ballooning without apical ballooning. Eur Heart J (2006) 1.08
Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. Int J Radiat Oncol Biol Phys (2009) 1.07
Low-dose analgesic radiotherapy is a real alternative. Dtsch Arztebl Int (2013) 1.06
Demographic, clinical and treatment related predictors for event-free probability following low-dose radiotherapy for painful heel spurs - a retrospective multicenter study of 502 patients. Acta Oncol (2007) 1.06
Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol (2005) 1.05
Genomic expansion and clustering of ZAD-containing C2H2 zinc-finger genes in Drosophila. EMBO Rep (2002) 1.05
Conformal therapy for pancreatic cancer: variation of organ position due to gastrointestinal distention--implications for treatment planning. Radiology (2002) 1.05
Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial. Strahlenther Onkol (2008) 1.04
Selective follicular targeting by modification of the particle sizes. J Control Release (2010) 1.03
Late effects of abdominal irradiation in children: a review of the literature. Anticancer Res (2010) 1.02
The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy. Anticancer Res (2005) 1.02
Gain-of-function screen for genes that affect Drosophila muscle pattern formation. PLoS Genet (2005) 1.02
Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys (2010) 1.01
German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results. Strahlenther Onkol (2007) 0.99
Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation. Radiother Oncol (2004) 0.98
Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys (2008) 0.98
Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol (2008) 0.97
Radiotherapy is effective for desmoid tumors (aggressive fibromatosis) - long-term results of a German multicenter study. Oncol Res Treat (2014) 0.97
Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2005) 0.96
Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant (2005) 0.96
Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison--lessons for future studies. PLoS One (2012) 0.96
Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study. Anticancer Res (2007) 0.95
Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol (2014) 0.95
Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease. Radiat Oncol (2013) 0.93
Systematic gene targeting on the X chromosome of Drosophila melanogaster. Chromosoma (2004) 0.93
Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys (2003) 0.93
Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry. Clin Res Cardiol (2012) 0.92
Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases. BMC Cancer (2012) 0.91
Long-term results of radiotherapy in primary carcinoma of the vagina. Strahlenther Onkol (2009) 0.90
Initiation of a teleradiotherapeutic network for patients in German lymphoma studies. Int J Radiat Oncol Biol Phys (2004) 0.90
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas. Radiat Oncol (2010) 0.90
Identification of Drosophila genes modulating Janus kinase/signal transducer and activator of transcription signal transduction. Genetics (2005) 0.89
Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys (2003) 0.89
Small cell cancer of the anal canal--case report of a rare tumor. Anticancer Res (2007) 0.89
[Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study]. Strahlenther Onkol (2006) 0.88
Hemithorax irradiation for Ewing tumors of the chest wall. Int J Radiat Oncol Biol Phys (2002) 0.87
Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin (2009) 0.87
Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Strahlenther Onkol (2003) 0.87
Langerhans cell histiocytosis of the cranial base: is low-dose radiotherapy effective? Case Rep Oncol Med (2012) 0.87
U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanism. J Cardiovasc Pharmacol (2010) 0.86
Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2014) 0.85
Solitary testicular metastasis from prostate cancer: a rare case of isolated recurrence after radical prostatectomy. Anticancer Res (2010) 0.85
Nutritional and toxicological importance of macro, trace, and ultra-trace elements in algae food products. J Agric Food Chem (2007) 0.85
Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial. EuroIntervention (2015) 0.85
A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (2002) 0.85
Retrospective, monocentric analysis of late effects after Total Body Irradiation (TBI) in adults. Strahlenther Onkol (2011) 0.84
The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. Altern Lab Anim (2008) 0.84
Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol (2002) 0.83
Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis. J Pharmacol Exp Ther (2005) 0.83
Perioperative high-dose rate brachytherapy using a bendy applicator (flab): treatment results of 74 patients. Anticancer Res (2009) 0.83
Radiotherapy in oncological emergencies--final results of a patterns of care study in Germany, Austria and Switzerland. Acta Oncol (2008) 0.83
[Percutaneous approaches for mitral valve interventions--a real alternative technique for standard cardiac surgery?]. Herz (2009) 0.82
Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon. Strahlenther Onkol (2007) 0.82
Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS). Strahlenther Onkol (2003) 0.82
Radiation-induced changes of telomerase activity in a human Ewing xenograft tumor. Strahlenther Onkol (2002) 0.82
Retracted Radiotherapy for giant cell tumors of the bone: a safe and effective treatment modality. Anticancer Res (2012) 0.82
Radiotherapy of splenomegaly : a palliative treatment option for a benign phenomenon in malignant diseases. Strahlenther Onkol (2011) 0.82
Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity. Apoptosis (2009) 0.82
Misexpression screen in Drosophila melanogaster aiming to reveal novel factors involved in formation of body parts. Genetics (2006) 0.82
Reducing radiation exposure during invasive coronary angiography and percutaneous coronary interventions implementing a simple four-step protocol. Clin Res Cardiol (2015) 0.81
Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients. Anticancer Res (2003) 0.81
Quantification of lymphedema in a rat model by 3D-active contour segmentation by magnetic resonance imaging. Lymphat Res Biol (2012) 0.81
Dose-volume analysis of radiation nephropathy in children: preliminary report of the risk consortium. Int J Radiat Oncol Biol Phys (2010) 0.81
Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2012) 0.80
Zinc concentrations in serum during head and neck cancer progression. Anticancer Res (2007) 0.80
Evidence for predictive validity of blood assays to evaluate individual radiosensitivity. Int J Radiat Oncol Biol Phys (2005) 0.80
12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas. Strahlenther Onkol (2005) 0.80